×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.

Become an Incathlab member and receive full access to its content!

You must be an Incathlab member to access videos without any restrictions. Register for free in one minute and access all services provided by Incathlab.You will also be able to log into Incathlab from your Facebook or twitter account by clicking on login on the top-right corner of Incathlab website.

Registration Login


20266 views


The treatment of Peripheral Artery Disease (PAD) has known an important evolution in the last years. An important limitation of current endovascular therapy remains the occurrence of restenosis. In order to minimize restenosis rates, Drug-Eluting Technologies (DET) are evolving. The use of drug-eluting stents (DES) in coronary arteries shows beneficial results, leading to investigation of DES in PAD.

In this web symposium, we give an overview of current available data on PAD treatment with drug eluting technologies.
Through video cases performed by expert operators, discover techniques and devices to improve the use of DET in your daily practice. 

Program

  • Debate with our experts : How Drug Eluting Technologies will revolutionize your practice?
  • 1st case : Calcified left SFA - Double access ( Antegrade + Retrograde)

  • How to use DET based on clinical data review in 2016? – Lecture by Dr Thomas Zeller
  • 2nd case : Polystenotic calcified right SFA Antegrade approach - DES and DEB combination therapy

  • Eluvia, designing a revolutionary drug eluting stent for SFA interventions – Lecture by Jaydeep Kokate
  • 3rd case : Short left superficial femoral artery Eluvia stenting

  • My experience in DET : indications and algorythm - Lecture by Dr Koen Deloose

Educational objectives

  • Discuss current trends and approaches to the treatment of PAD with the use of DET, in terms of patient’s outcomes
  • Demonstrate advanced techniques and new drug eluting technologies in the treatment of peripheral artery disease
  • Provide platform for discussion and mutual learning

Audience

  • Endovascular specialists (Vascular Surgeons, Interventional Radiologists, Interventional Angiologists and Interventional Cardiologists)
  • Referring physicians of patients with peripheral artery disease
Shooting date : 2016-07-13
Last update : 2021-06-09
Max Amor
Essey-lès-Nancy, France
Koen Deloose
Dendermonde, Belgium
Thomas Zeller
Bad Krozingen, Germany

Suggestions

Thursday, September 7th 2017 from 12pm to 01:30pm (GMT+2)
Honolulu : Thursday, September 7th 2017 from 01am to 02:30am (GMT+2)
San Francisco : Thursday, September 7th 2017 from 04am to 05:30am (GMT+2)
New York : Thursday, September 7th 2017 from 07am to 08:30am (GMT+2)
Buenos Aires : Thursday, September 7th 2017 from 08am to 09:30am (GMT+2)
Reykjavik : Thursday, September 7th 2017 from 11am to 12:30pm (GMT+2)
London / Dublin : Thursday, September 7th 2017 from 12pm to 01:30pm (GMT+2)
Paris / Berlin : Thursday, September 7th 2017 from 01pm to 02:30pm (GMT+2)
Istanbul : Thursday, September 7th 2017 from 02pm to 03:30pm (GMT+2)
Moscou / Dubaï : Thursday, September 7th 2017 from 03pm to 04:30pm (GMT+2)
Bangkok : Thursday, September 7th 2017 from 06pm to 07:30pm (GMT+2)
Shanghai : Thursday, September 7th 2017 from 07pm to 08:30pm (GMT+2)
Tokyo : Thursday, September 7th 2017 from 08pm to 09:30pm (GMT+2)
Sydney : Thursday, September 7th 2017 from 10pm to 11:30pm (GMT+2)
Wellington : Friday, September 8th 2017 from 12am to 01:30am (GMT+2)

The best choice in SFA procedures depending on multiple factors (Live Session)

Clinical - Anatomical - Cost efficiency

Share

CLIC 2019: Live Case #2

Dr Shannon D. Thomas, Dr Elena Herrero & Dr Luis Mariano Palena

Share
Scroll Up